PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15240547-6	2004	Dicumarol increased the percentage of apoptotic cells in a time-dependent and dose-dependent manner as measured by 3,3"-diaminobenzidine staining and flow cytometry, which was associated with cytochrome c release and poly(ADP-ribose) polymerase cleavage.	Dicumarol	0-9	poly(ADP-ribose) polymerase 1	Homo sapiens	217-244	
11412042-6	2001	Atypical PARP cleavage in beta-lap-treated cells was not affected by 100 microM zVAD-fmk; however, coadministration of dicoumarol, a specific inhibitor of NQO1, reduced beta-lap-mediated cytotoxicity, apoptosis, and atypical PARP cleavage in NQO1-expressing cells.	Dicumarol	119-129	poly(ADP-ribose) polymerase 1	Homo sapiens	9-13	
11412042-6	2001	Atypical PARP cleavage in beta-lap-treated cells was not affected by 100 microM zVAD-fmk; however, coadministration of dicoumarol, a specific inhibitor of NQO1, reduced beta-lap-mediated cytotoxicity, apoptosis, and atypical PARP cleavage in NQO1-expressing cells.	Dicumarol	119-129	poly(ADP-ribose) polymerase 1	Homo sapiens	225-229